Skip to main content

GPCR Structures

UniProtUnique IDChainName Ligand Species ResolutionDate releasedParent PDBa b c alphabetagammaSpace Group
P026991f88AARhodopsin retinal Bos taurus 2.84 Aug 20001f8897.24697.246149.54490.0090.0090.00P 41
P026991f88BBRhodopsin retinal Bos taurus 2.84 Aug 20001f8897.24697.246149.54490.0090.0090.00P 41
P026991hzxAARhodopsin retinal Bos taurus 2.84 Jul 20011hzx97.24697.246149.54490.0090.0090.00P 41
P026991hzxBBRhodopsin retinal Bos taurus 2.84 Jul 20011hzx97.24697.246149.54490.0090.0090.00P 41
P026991l9hAARhodopsin retinal Bos taurus 2.615 May 20021l9h96.74596.745149.30090.0090.0090.00P 41
P026991l9hBBRhodopsin retinal Bos taurus 2.615 May 20021l9h96.74596.745149.30090.0090.0090.00P 41
P026991u19AARhodopsin retinal Bos taurus 2.212 Oct 20041u1996.68096.680150.20090.0090.0090.00P 41
P026991u19BBRhodopsin retinal Bos taurus 2.212 Oct 20041u1996.68096.680150.20090.0090.0090.00P 41
P026992g87AARhodopsin retinal Bos taurus 2.62 Mar 20062g8796.49096.490150.40090.0090.0090.00P 41
P026992g87BBRhodopsin retinal Bos taurus 2.62 Mar 20062g8796.49096.490150.40090.0090.0090.00P 41
P026992hpyAARhodopsin retinal Bos taurus 2.818 Jul 20062hpy96.72096.720150.40090.0090.0090.00P 41
P026992hpyBBRhodopsin retinal Bos taurus 2.818 Jul 20062hpy96.72096.720150.40090.0090.0090.00P 41
P026992i35 ARhodopsin retinal Bos taurus 3.817 Oct 20062i35277.534277.53466.32190.0090.00120.00H 3 2
P026992i36AARhodopsin apo Bos taurus 4.117 Oct 20062i36159.866159.866142.15090.0090.00120.00P 31 1 2
P026992i36BBRhodopsin apo Bos taurus 4.117 Oct 20062i36159.866159.866142.15090.0090.00120.00P 31 1 2
P026992i36CCRhodopsin apo Bos taurus 4.117 Oct 20062i36159.866159.866142.15090.0090.00120.00P 31 1 2
P026992i37AARhodopsin apo Bos taurus 4.117 Oct 20062i37161.245161.245143.44290.0090.00120.00P 31 1 2
P026992i37BBRhodopsin apo Bos taurus 4.117 Oct 20062i37161.245161.245143.44290.0090.00120.00P 31 1 2
P026992i37CCRhodopsin apo Bos taurus 4.117 Oct 20062i37161.245161.245143.44290.0090.00120.00P 31 1 2
P026992j4yAARhodopsin retinal Bos taurus 3.425 Sep 20072j4y109.300109.30077.70090.0090.00120.00P 31
P026992j4yBBRhodopsin retinal Bos taurus 3.425 Sep 20072j4y109.300109.30077.70090.0090.00120.00P 31
P026992pedAARhodopsin retinal Bos taurus 2.92 Apr 20072ped95.96095.960150.84090.0090.0090.00P 41
P026992pedBBRhodopsin retinal Bos taurus 2.92 Apr 20072ped95.96095.960150.84090.0090.0090.00P 41
P026993capAARhodopsin apo Bos taurus 2.924 Jun 20083cap242.917242.918110.42090.0090.00120.00H 3
P026993capBBRhodopsin apo Bos taurus 2.924 Jun 20083cap242.917242.918110.42090.0090.00120.00H 3
P026993dqb ARhodopsin apo Bos taurus 3.223 Sep 20083dqb238.020238.020109.13290.0090.00120.00H 3 2
P026993c9l ARhodopsin retinal Bos taurus 2.65 Aug 20083c9l103.820103.82076.59090.0090.00120.00P 64
P026993c9m ARhodopsin retinal Bos taurus 3.416 Feb 20083c9m109.300109.30077.70090.0090.00120.00P 64
P026991gzmAARhodopsin retinal Bos taurus 2.620 Nov 20031gzm103.820103.82076.59090.0090.00120.00P 31
P026991gzmBBRhodopsin retinal Bos taurus 2.620 Nov 20031gzm103.820103.82076.59090.0090.00120.00P 31
P313562z73AARhodopsin retinal Todarodes pacificus2.513 May 20082z73122.550122.550158.74090.0090.00120.00P 62
P313562z73BBRhodopsin retinal Todarodes pacificus2.513 May 20082z73122.550122.550158.74090.0090.00120.00P 62
P313562ziyAARhodopsin retinal Todarodes pacificus3.727 Feb 20082ziy84.319108.746142.16590.0090.0090.00C 2 2 21
P313563aymAARhodopsin retinal Todarodes pacificus2.89 May 20113aym122.360122.360158.22090.0090.00120.00P 62
P313563aymBARhodopsin retinal Todarodes pacificus2.89 May 20113aym122.360122.360158.22090.0090.00120.00P 62
P313563aynAARhodopsin retinal Todarodes pacificus2.79 May 20113ayn122.540122.540158.53090.0090.00120.00P 62
P313563aynBARhodopsin retinal Todarodes pacificus2.79 May 20113ayn122.540122.540158.53090.0090.00120.00P 62
P075502r4r Abeta-2 Adrenergic receptorapo Homo sapiens 3.46 Nov 20072r4r338.38048.48089.35090.00104.6090.00C 1 2 1
P075502r4s Abeta-2 Adrenergic receptorapo Homo sapiens 3.46 Nov 20072r4s338.38048.48089.35090.00104.6090.00C 1 2 1
P075502rh1 Abeta-2-Adrenergic receptorCarazolol Homo sapiens 2.430 Oct 20072rh1106.318169.24040.15490.00105.6290.00C 1 2 1
P075503d4s Abeta-2 Adrenergic receptorTimolol Homo sapiens 2.817 Jun 20083d4s40.00075.700172.73090.0090.0090.00P 21 21 21
P075503kj6 Abeta-2 Adrenergic receptorapo Homo sapiens 3.416 Feb 20103kj6338.60048.60088.90090.00104.4090.00C 1 2 1
P075503ny8 Abeta-2 Adrenergic receptorICI-118551 Homo sapiens 2.811 Aug 20103ny840.71176.148174.20790.0090.0090.00P 21 21 21
P075503ny9 Abeta-2 Adrenergic receptorICI-118551 analogueHomo sapiens 2.811 Aug 20103ny940.58075.900174.18090.0090.0090.00P 21 21 21
P075503nya Abeta-2 Adrenergic receptorAlprenolol Homo sapiens 3.211 Aug 20103nya40.57775.730173.40390.0090.0090.00P 21 21 21
P075503p0gAAbeta-2 Adrenergic receptor8-[(1R)-2-{[1,1-dimethyl-2-(2-methylphenyl)ethyl]amino}-1-hydroxyethyl]-5-hydroxy-2H-1,4-benzoxazin-3(4H)-oneHomo sapiens 3.528 Sep 20103p0g236.68645.66071.37590.00102.3490.00C 1 2 1
P075503pdsAAbeta-2 Adrenergic receptor8-hydroxy-5-[(1R)-1-hydroxy-2-({2-[3-methoxy-4-(3-sulfanylpropoxy)phenyl]ethyl}amino)ethyl]quinolin-2(1H)-oneHomo sapiens 3.524 Oct 20103pds282.44040.04065.21090.0090.0090.00P 21 21 2
P075503sn6RRbeta-2 Adrenergic receptor8-[(1R)-2-{[1,1-dimethyl-2-(2-methylphenyl)ethyl]amino}-1-hydroxyethyl]-5-hydroxy-2H-1,4-benzoxazin-3(4H)-oneHomo sapiens 3.228 Jun 20113sn6119.33964.555131.24090.0091.6790.00P 1 21 1
P077002vt4AAbeta-1 Adrenergic receptorCyanopindolol Meleagris gallopavo2.724 Jun 20082vt455.50086.80095.50067.6073.3085.80P 1
P077002vt4BBbeta-1 Adrenergic receptorCyanopindolol Meleagris gallopavo2.724 Jun 20082vt455.50086.80095.50067.6073.3085.80P 1
P077002vt4CCbeta-1 Adrenergic receptorCyanopindolol Meleagris gallopavo2.724 Jun 20082vt455.50086.80095.50067.6073.3085.80P 1
P077002vt4DDbeta-1 Adrenergic receptorCyanopindolol Meleagris gallopavo2.724 Jun 20082vt455.50086.80095.50067.6073.3085.80P 1
P077002y00AAbeta-1 Adrenergic receptorDobutamine Meleagris gallopavo2.530 Nov 20102y0090.00060.500101.90090.00110.2090.00P 1 21 1
P077002y00BBbeta-1 Adrenergic receptorDobutamine Meleagris gallopavo2.530 Nov 20102y0090.00060.500101.90090.00110.2090.00P 1 21 1
P077002y01AAbeta-1 Adrenergic receptorDobutamine Meleagris gallopavo2.630 Nov 20102y0190.10061.600101.40090.00108.9090.00P 1 21 1
P077002y01BBbeta-1 Adrenergic receptorDobutamine Meleagris gallopavo2.630 Nov 20102y0190.10061.600101.40090.00108.9090.00P 1 21 1
P077002y02AAbeta-1 Adrenergic receptorCarmoterol Meleagris gallopavo2.630 Nov 20102y0289.60061.700101.40090.00109.3090.00P 1 21 1
P077002y02BBbeta-1 Adrenergic receptorCarmoterol Meleagris gallopavo2.630 Nov 20102y0289.60061.700101.40090.00109.3090.00P 1 21 1
P077002y03AAbeta-1 Adrenergic receptorIsoprenaline Meleagris gallopavo2.930 Nov 20102y0389.70061.600101.60090.00109.7090.00P 1 21 1
P077002y03BBbeta-1 Adrenergic receptorIsoprenaline Meleagris gallopavo2.930 Nov 20102y0389.70061.600101.60090.00109.7090.00P 1 21 1
P077002y04AAbeta-1 Adrenergic receptorSalbutamol Meleagris gallopavo3.130 Nov 20102y0489.90062.000101.50090.00109.9090.00P 1 21 1
P077002y04BBbeta-1 Adrenergic receptorSalbutamol Meleagris gallopavo3.130 Nov 20102y0489.90062.000101.50090.00109.9090.00P 1 21 1
P077002ycwAAbeta-1 Adrenergic receptorS-Carazolol Meleagris gallopavo3.017 Mar 20112ycw89.39857.056109.54290.00113.5290.00P 1 21 1
P077002ycwBBbeta-1 Adrenergic receptorS-Carazolol Meleagris gallopavo3.017 Mar 20112ycw89.39857.056109.54290.00113.5290.00P 1 21 1
P077002ycxAAbeta-1 Adrenergic receptorCyanopindolol Meleagris gallopavo3.217 Mar 20112ycx150.02956.434111.41090.00118.3390.00C 1 2 1
P077002ycxBBbeta-1 Adrenergic receptorCyanopindolol Meleagris gallopavo3.217 Mar 20112ycx150.02956.434111.41090.00118.3390.00C 1 2 1
P077002ycyAAbeta-1 Adrenergic receptorCyanopindolol Meleagris gallopavo3.117 Mar 20112ycy184.76056.16189.77890.00111.2790.00C 1 2 1
P077002ycyBBbeta-1 Adrenergic receptorCyanopindolol Meleagris gallopavo3.117 Mar 20112ycy184.76056.16189.77890.00111.2790.00C 1 2 1
P077002yczAAbeta-1 Adrenergic receptorIodocyanopindolol Meleagris gallopavo3.617 Mar 20112ycz177.85556.298110.93990.00116.3990.00C 1 2 1
P077002yczBBbeta-1 Adrenergic receptorIodocyanopindolol Meleagris gallopavo3.617 Mar 20112ycz177.85556.298110.93990.00116.3990.00C 1 2 1
P081723uon AMuscarinic receptor M2 QNB Homo sapiens 3.016 Nov 20113uon78.17047.26088.12090.00109.7090.00P 1 21 1
P354623pblAADopamine receptor D3 Eticlopride Homo sapiens 2.920 Oct 20103pbl88.82892.492176.11690.0090.0090.00P 21 21 21
P354623pblBBDopamine receptor D3 Eticlopride Homo sapiens 2.920 Oct 20103pbl88.82892.492176.11690.0090.0090.00P 21 21 21
P353673rze AHistamine receptor H1 Doxepin Homo sapiens 3.122 Jun 20113rze88.14488.144331.65490.0090.0090.00I 4 2 2
P214533v2w ASphingosine-1-phosphate receptor{(3R)-3-amino-4-[(3-hexylphenyl)amino]-4-oxobutyl}phosphonic acidHomo sapiens 3.312 Dec 20113v2w107.94069.70081.93090.0090.0090.00P 21 21 2
P292743eml AAdenosine A2a receptor ZM-241385 Homo sapiens 2.614 Oct 20083eml47.73676.93286.55390.00101.3290.00P 1 21 1
P292743qak AAdenosine A2a receptor UK-432097 Homo sapiens 2.711 Jan 20113qak47.83678.94486.57990.00100.5490.00P 1 21 1
P292742ydo AAdenosine A2a receptor adenosine Homo sapiens 3.018 May 20112ydo76.46598.86979.51690.0093.4990.00C 1 2 1
P292742ydv AAdenosine A2a receptor NECA Homo sapiens 2.718 May 20112ydv76.93699.55179.65590.0093.3190.00C 1 2 1
P292743pwh AAdenosine A2a receptor ZM-241385 Homo sapiens 3.38 Dec 20103pwh111.935112.551125.67890.0090.0090.00I 2 2 2
P292743rey AAdenosine A2a receptor XAC Homo sapiens 3.35 Apr 20113rey111.865113.061126.80290.0090.0090.00I 2 2 2
P292743rfm AAdenosine A2a receptor Caffeine Homo sapiens 3.66 Apr 20113rfm112.327113.328129.30090.0090.0090.00I 2 2 2
P610733oduAAChemokine receptor type 4 IT1t Homo sapiens 2.527 Oct 20103odu64.54083.692 119.99590.00102.1790.00P 1 21 1
P610733oduBBChemokine receptor type 4 IT1t Homo sapiens 2.527 Oct 20103odu64.54083.692 119.99590.00102.1790.00P 1 21 1
P610733oe0AAChemokine receptor type 4 CVX-15 Homo sapiens 2.927 Oct 20103oe082.080144.860 73.99090.00104.5490.00C 1 2 1
P610733oe6AAChemokine receptor type 4 IT1t Homo sapiens 3.227 Oct 20103oe671.12178.711 240.59290.0090.0090.00I 2 2 2
P610733oe8AAChemokine receptor type 4 IT1t Homo sapiens 3.127 Oct 20103oe869.36976.602 91.71996.0097.7897.38P 1
P610733oe8BBChemokine receptor type 4 IT1t Homo sapiens 3.127 Oct 20103oe869.36976.602 91.71996.0097.7897.38P 1
P610733oe8CCChemokine receptor type 4 IT1t Homo sapiens 3.127 Oct 20103oe869.36976.602 91.71996.0097.7897.38P 1
P610733oe9AAChemokine receptor type 4 IT1t Homo sapiens 3.127 Oct 20103oe972.49772.739 84.27364.6673.9361.31P 1
P610733oe9BBChemokine receptor type 4 IT1t Homo sapiens 3.127 Oct 20103oe972.49772.739 84.27364.6673.9361.31P 1

Popular posts from this blog

ChEMBL 34 is out!

We are delighted to announce the release of ChEMBL 34, which includes a full update to drug and clinical candidate drug data. This version of the database, prepared on 28/03/2024 contains:         2,431,025 compounds (of which 2,409,270 have mol files)         3,106,257 compound records (non-unique compounds)         20,772,701 activities         1,644,390 assays         15,598 targets         89,892 documents Data can be downloaded from the ChEMBL FTP site:  https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/ Please see ChEMBL_34 release notes for full details of all changes in this release:  https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/chembl_34_release_notes.txt New Data Sources European Medicines Agency (src_id = 66): European Medicines Agency's data correspond to EMA drugs prior to 20 January 2023 (excluding vaccines). 71 out of the 882 newly added EMA drugs are only authorised by EMA, rather than from other regulatory bodies e.g.

New SureChEMBL announcement

(Generated with DALL-E 3 ∙ 30 October 2023 at 1:48 pm) We have some very exciting news to report: the new SureChEMBL is now available! Hooray! What is SureChEMBL, you may ask. Good question! In our portfolio of chemical biology services, alongside our established database of bioactivity data for drug-like molecules ChEMBL , our dictionary of annotated small molecule entities ChEBI , and our compound cross-referencing system UniChem , we also deliver a database of annotated patents! Almost 10 years ago , EMBL-EBI acquired the SureChem system of chemically annotated patents and made this freely accessible in the public domain as SureChEMBL. Since then, our team has continued to maintain and deliver SureChEMBL. However, this has become increasingly challenging due to the complexities of the underlying codebase. We were awarded a Wellcome Trust grant in 2021 to completely overhaul SureChEMBL, with a new UI, backend infrastructure, and new f

Accessing SureChEMBL data in bulk

It is the peak of the summer (at least in this hemisphere) and many of our readers/users will be on holiday, perhaps on an island enjoying the sea. Luckily, for the rest of us there is still the 'sea' of SureChEMBL data that awaits to be enjoyed and explored for hidden 'treasures' (let me know if I pushed this analogy too far). See here and  here for a reminder of SureChEMBL is and what it does.  This wealth of (big) data can be accessed via the SureChEMBL interface , where users can submit quite sophisticated and granular queries by combining: i) Lucene fields against full-text and bibliographic metadata and ii) advanced structure query features against the annotated compound corpus. Examples of such queries will be the topic of a future post. Once the search results are back, users can browse through and export the chemistry from the patent(s) of interest. In addition to this functionality, we've been receiving user requests for  local (behind the

New Drug Approvals - Pt. XVII - Telavancin (Vibativ)

The latest new drug approval, on 11th September 2009 was Telavancin - which was approved for the treatment of adults with complicated skin and skin structure infections (cSSSI) caused by susceptible Gram-positive bacteria , including Staphylococcus aureus , both methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) strains. Telavancin is also active against Streptococcus pyogenes , Streptococcus agalactiae , Streptococcus anginosus group (includes S. anginosus, S. intermedius and S. constellatus ) and Enterococcus faecalis (vancomycin susceptible isolates only). Telavancin is a semisynthetic derivative of Vancomycin. Vancomycin itself is a natural product drug, isolated originally from soil samples in Borneo, and is produced by controlled fermentation of Amycolatopsis orientalis - a member of the Actinobacteria . Telavancin has a dual mechanism of action, firstly it inhibits bacterial cell wall synthesis by interfering with the polymerization and cross-linking of peptid

A python client for accessing ChEMBL web services

Motivation The CheMBL Web Services provide simple reliable programmatic access to the data stored in ChEMBL database. RESTful API approaches are quite easy to master in most languages but still require writing a few lines of code. Additionally, it can be a challenging task to write a nontrivial application using REST without any examples. These factors were the motivation for us to write a small client library for accessing web services from Python. Why Python? We choose this language because Python has become extremely popular (and still growing in use) in scientific applications; there are several Open Source chemical toolkits available in this language, and so the wealth of ChEMBL resources and functionality of those toolkits can be easily combined. Moreover, Python is a very web-friendly language and we wanted to show how easy complex resource acquisition can be expressed in Python. Reinventing the wheel? There are already some libraries providing access to ChEMBL d